argus

Cipla Ltd.

NSE: CIPLAINE059A010261,14,093 Cr

Timeline

Time (IST)TypeMEventSrc
31 Aug, 03:53 pmother2Cipla and SBP Group sign exclusive licensing agreement for potential best-in-class HER2 bispecific ADC Rolditamig Deuderuxtecan (TQB2102).nse
31 Aug, 03:42 pmCipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
28 Aug, 09:11 pmCipla Limited has informed the Exchange about Update on USFDA inspection at InvaGen manufacturing facility in Central Islip, Long Island, NY, USAnse
27 Aug, 08:19 pmCipla Limited has informed the Exchange about Other Restructuringnse
27 Aug, 08:15 pmCipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Restructuringbse
25 Aug, 04:11 pmCipla Limited has informed the Exchange about USFDA inspection at Company s manufacturing facility in Pithampur, Indianse
19 Aug, 05:04 pmCipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Scheme of Arrangementbse
19 Aug, 05:01 pmCipla Limited has informed the Exchange about receipt of order from Hon'ble NCLT, Mumbai Bench.nse
11 Aug, 01:25 pmCipla Limited has informed the Exchange about ESG Ratings.nse
11 Aug, 01:24 pmCipla Ltd - 500087 - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
04 Aug, 08:57 amUpdate on USFDA inspection at InvaGen manufacturing facility in Hauppauge, Long Island, New York, USAnse
31 Jul, 10:18 pmCipla Limited has informed the Exchange regarding allotment of 7850 securities pursuant to ESOP/ESPS at its meeting held on July 31, 2026nse
27 Jul, 10:55 pmCipla Limited has informed the Exchange regarding 'Cipla Receives U.S. FDA Approval for Generic Advair Diskus®'.nse
27 Jul, 05:15 pmCipla Limited has informed the Exchange about Transcriptnse
27 Jul, 05:12 pmCipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
24 Jul, 03:55 pmCipla Limited has informed the Exchange about Copy of Newspaper Publication of the unaudited financial results for the quarter ended 30th June, 2026.nse
23 Jul, 07:28 pmCipla Limited has informed the Exchange about Link of Recordingnse
23 Jul, 07:24 pmCipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
23 Jul, 04:20 pmCipla Ltd - 500087 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
23 Jul, 01:40 pmCipla Ltd - 500087 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
23 Jul, 01:36 pmCipla Ltd - 500087 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
23 Jul, 01:32 pmCipla Ltd - 500087 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
23 Jul, 01:31 pmCipla Limited has informed the Exchange that the Board has approved the changes in the Key Managerial Personnels (KMPs) and Officers authorised under Regulation 30(5) of the SEBI Listing Regulations.nse
23 Jul, 01:30 pmCipla Ltd - 500087 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
23 Jul, 01:24 pmCipla Limited has informed the Exchange regarding 'Grant Of Stock Options and Employee Stock Appreciation Rights'.nse
23 Jul, 01:20 pmCipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Change in Managementbse
23 Jul, 01:17 pmCipla Limited has informed the Exchange about change in management.nse
23 Jul, 01:17 pmCipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Change in Managementbse
23 Jul, 01:14 pmCipla Limited has informed the Exchange regarding Outcome of Board Meeting held on July 23, 2026.nse
23 Jul, 12:43 pmCipla Limited has informed the Exchange regarding a press release dated July 23, 2026, titled 'Q1 FY27 Results'nse
23 Jul, 12:39 pmCipla Limited has informed the Exchange about Investor Presentationnse
23 Jul, 12:39 pmCipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
23 Jul, 12:38 pmCipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
23 Jul, 12:00 pmCipla Limited has submitted to the Exchange, the financial results for the period ended June 30, 2026.nse
23 Jul, 11:56 amCipla Ltd - 500087 - Financial Results For Quarter Ended 30Th June, 2026bse
18 Jul, 09:32 amCipla Limited has informed the Exchange about USFDA inspection at InvaGen manufacturing facility in Central Islip, Long Island, NY, USAnse
12 Jul, 11:31 amCipla Limited has informed the Exchange about ESG Rating.nse
12 Jul, 11:26 amCipla Ltd - 500087 - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
04 Jul, 06:58 pmCipla Limited has informed the Exchange regarding corrigendum to the intimation dated 3rd July, 2026 regarding 'Transcript of the 90th Annual General Meeting'nse
03 Jul, 06:45 pmCipla Limited has informed the Exchange regarding 'Transcript of the 90th Annual General Meeting '.nse
25 Jun, 10:02 pmCipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sbse
25 Jun, 09:59 pmCipla Limited has informed the Exchange regarding Change in Auditors of the company.nse
25 Jun, 03:02 pmCipla Limited has informed the Exchange about ESG Rating.nse
25 Jun, 03:02 pmCipla Ltd - 500087 - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
24 Jun, 05:56 pmCipla Ltd - 500087 - Board Meeting Intimation for The Quarter Ended 30Th June, 2026 Under SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
19 Jun, 03:37 pmDr. Y. K. Hamied has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) and 31 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
16 Jun, 01:18 pmCipla Limited has informed the Exchange regarding 'Grant Of Stock Options and Employee Stock Appreciation Rights'.nse
16 Jun, 01:09 pmCipla Limited has informed the Exchange about change in Managementnse
16 Jun, 01:08 pmCipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Change in Managementbse
11 Jun, 02:05 pmregulatory_action1Cipla informed the exchange that the USFDA inspected its manufacturing facility in Verna, Goa, India.nse